Fertility Preservation Concierge Services Market

What is the fertility preservation concierge services market forecast to be worth by 2036?

USD 3.0 billion in 2026 to USD 32.50 billion by 2036, at 26.9% CAGR.

• The fertility preservation concierge services market crossed an estimated USD 2.36 billion in 2025. Demand is expected to increase from USD 3.0 billion in 2026 to USD 32.50 billion by 2036.
• The market is forecast to record 26.9% CAGR during 2026 to 2036 as employer benefit platforms, oncology referral teams and clinic-linked navigation providers handle more preservation cases.
• Service revenue from navigation, benefit administration, counseling coordination and preservation planning forms the core of this market. The Centers for Disease Control and Prevention reported 435,426 assisted reproductive technology cycles at 457 reporting United States clinics in 2022.
• This supports service demand because 184,423 cycles were egg or embryo banking cycles where material was frozen for future use. 

What are the defining numbers behind fertility preservation concierge services growth?

USD 29.50 billion absolute opportunity by 2036, led by India and China.

• Demand Drivers in the Market
  • Employer benefit sponsors need navigation because fertility preservation claims require eligibility checks, clinic routing and member education.
  • Cancer-care teams need fast referral coordination because counseling must happen before chemotherapy, surgery or radiation begins.
  • Self-pay patients need financial guidance because procedure fees, medicine costs and storage fees are usually billed separately.
  • Regulated storage consent creates service demand because patients must understand ownership, renewal and disposition choices before cryopreservation.
• Key Segments Analyzed
  • By Service Type: Benefit Management is expected to hold 34.0% share in 2026 because employers and health plans need claims review, member support and clinic network control.
  • By Preservation Pathway: Egg Freezing leads because elective preservation requires counseling before medication starts. The segment is projected to capture 38.0% share in 2026.
  • By Buyer Type: Employers are likely to account for 46.0% share in 2026 since fertility access is increasingly funded through contracted benefit programs.
  • By Delivery Model: Virtual Concierge is projected to hold 41.0% share in 2026 as intake, cost checks and clinic matching often begin before a facility visit.
  • By End Use: Elective Preservation is expected to hold 42.0% share in 2026 due to delayed parenthood planning creates repeat counseling and cost-comparison needs.
  • By Geography: India is projected to record 29.6% CAGR through 2036 as clinic registration and urban self-pay pathways expand.
• Analyst Opinion at Fact.MR
  • Shambhu Nath Jha, Senior Analyst at Fact.MR, states, “Fertility preservation concierge services are becoming the planning layer between a patient, a clinic and a payer. I see the clearest advantage with providers that explain cost, storage choices and timing before a patient starts medication. Clients are paying for more than clinic access. They are paying for fewer delays, clearer decisions and stronger documentation around preserved reproductive material.”
• Strategic Implications
  • Benefit platforms should separate preservation navigation from broader family-building support because timing and storage decisions are more time-sensitive.
  • Fertility clinics need clearer concierge intake workflows before patients start medication or oncology treatment.
  • Employers should define preservation eligibility, storage limits and claims rules before program launch.
  • Self-pay channels need transparent cost guidance that explains procedure, pharmacy and storage bills separately.

India is projected to record 29.6% CAGR through 2036 as formal clinic registration improves referral visibility. China is expected to expand at 28.4% CAGR because treatment volumes create stronger clinic-routing needs. The United States is forecast to advance at 27.1% CAGR as employer-funded benefits and state preservation mandates create more eligibility checks. Japan is expected to advance at 26.8% CAGR as older maternal age and reimbursement-linked access shape preservation counseling. The United Kingdom is projected to rise at 26.2% CAGR because regulated storage rules make patient education more important.

How does the fertility preservation concierge services market break down by segment?

Benefit management leads at 34.0%; egg freezing leads at 38.0%.

Which service type leads?

Benefit Management holds 34.0% share in 2026.

Benefit Management is expected to hold 34.0% share in 2026 because employers and health plans need eligibility checks, claims support, care routing and reporting. Progyny reported 555 fertility and family-building clients as of December 31, 2025. That client base shows why service revenue is concentrated where employers need contracted administration and care management. 

Which preservation pathway leads?

Egg Freezing holds 38.0% share in 2026.

Egg Freezing leads because elective preservation needs age counseling, cost explanation, medication planning and storage guidance before treatment starts. The pathway also connects concierge teams with IVF devices because clinical procedures shape patient cost estimates and referral decisions.

Which buyer type leads?

Employers hold 46.0% share in 2026.

Employers lead because fertility preservation support is often purchased through workforce benefits. Carrot states that it provides care in 195+ countries and has 17,000+ eligible providers. This type of network scale helps employers offer fertility navigation without building their own provider-management teams. 

Which delivery model leads?

Virtual Concierge holds 41.0% share in 2026.

Virtual Concierge leads because first questions usually involve timing, cost and eligibility rather than clinical procedures. Remote intake also links to home diagnostics when programs use at-home testing or pre-clinic health screening to move patients toward the right care pathway.

Which end use leads?

Elective Preservation holds 42.0% share in 2026.

Elective Preservation leads early service revenue because patients need help deciding whether age, treatment goals and storage cost justify freezing. Oncofertility has smaller volume but higher urgency because referral must occur before gonadotoxic therapy begins.

Which pricing model leads?

Per-Member Fee pricing holds 37.0% share in 2026.

Per-Member Fee pricing leads because employers prefer predictable spending before member claims occur. Case-fee and bundled-plan models remain useful in self-pay channels where patients enter active preservation support after a clinical inquiry.

What is accelerating fertility preservation concierge services demand, and what is holding it back?

Assisted reproduction volume and benefit administration drive it; affordability and counseling capacity restrain it.

The main driver is treatment complexity. Assisted reproductive technology involves medical timing, laboratory handling, consent forms, payment choices and storage decisions. Concierge demand rises because a patient needs one route through these steps rather than separate conversations with a clinic, employer, insurer and storage provider. Concierge services sit around assisted reproductive technology because the service layer converts procedure decisions into benefit rules, clinic options and storage choices.

Another driver is preservation urgency. The American Society for Reproductive Medicine states that patients receiving treatment that may affect gonads should be informed about fertility preservation before treatment starts. This makes oncofertility referral coordination a practical service need rather than a general education task. 

The main restraint is affordability. Concierge support can reduce confusion, but it does not remove procedure fees, medication costs or storage charges. Adoption is also constrained by counseling capacity because professional guidance may need physicians, nurses, mental health professionals and financial counselors in the same pathway. 

Where do the biggest fertility preservation concierge opportunities sit?

Oncofertility referral, employer benefit administration and storage lifecycle support.

• Oncofertility Referral: Providers can build fast pathways between oncology teams and fertility clinics before treatment begins.
• Employer Benefits: Platforms can add preservation-specific eligibility checks, storage counseling and claims support to existing family-building programs.
• Storage Lifecycle: Clinics and benefits providers can support renewal, consent updates and disposition decisions after the original preservation cycle.
• Treatment Planning: Concierge teams can explain sperm processing media and preimplantation genetic testing when patients ask how stored material may be used in later treatment.

Which countries are scaling fertility preservation concierge services fastest?

India 29.6%, China 28.4%, United States 27.1%, Japan 26.8%, United Kingdom 26.2%, Australia 25.6%, Spain 24.7%.

Based on regional analysis, the fertility preservation concierge services market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

What is powering India's lead?

29.6% CAGR, supported by formal clinic registration and self-pay care navigation.

India is projected to record 29.6% CAGR through 2036 as formal clinic registration improves referral screening and patient confidence. The Government of India reported 2,574 registered assisted reproductive technology clinics and 632 registered banks in August 2025. This creates a visible clinic base that helps concierge providers explain clinic status, price pathways and preservation rules. Birla Fertility and IVF, Nova IVF Fertility, Indira IVF and Oasis Fertility are active local providers. Demand favors services that translate regulation into simple patient routing. [12]

How is China scaling service demand?

28.4% CAGR, supported by treatment volume and coordinated clinic referral needs.

China is expected to expand at 28.4% CAGR through 2036 because fertility treatment volume creates a service gap between hospital capacity and patient decision-making. A peer-reviewed 2024 analysis reported 536 assisted reproductive technology institutions connected to National Health Commission records. That base supports demand for clinic matching, timing guidance and payment explanation. Jinxin Fertility Group, United Family Healthcare and regional reproductive centers are active providers. Growth is constrained when patients outside large cities face limited access to specialist counseling. [14]

What supports the United States outlook?

27.1% CAGR, supported by employer benefit funding and state preservation mandates.

The United States is forecast to advance at 27.1% CAGR through 2036 because employer-funded fertility benefits and state preservation mandates create recurring service work. The Centers for Disease Control and Prevention reported 435,426 assisted reproductive technology cycles at 457 reporting clinics in 2022. Benefit vendors such as Progyny, Carrot Fertility, Maven Clinic, Kindbody, WIN and ARC Fertility compete by guiding members through clinic choice and payment rules. Employer benefit platforms also connect preservation planning with home DNA testing when programs include reproductive risk discussion. [2]

Why is Japan an important service market?

26.8% CAGR, supported by older maternal age and reimbursement-linked treatment access.

Japan is expected to advance at 26.8% CAGR through 2036 as older maternal age and formal treatment access increase counseling needs. Reproductive Medicine and Biology reported 561,664 assisted reproductive technology cycles and 85,048 newborns in Japan for 2023. Kato Ladies Clinic, Sugiyama Clinic, IVF Japan Group and Oak Clinic are active local providers. Buyers in Japan value clear clinical explanation, age-linked expectations and cautious storage guidance before preservation starts. [15]

What underpins the United Kingdom's growth?

26.2% CAGR, backed by regulated storage counseling and egg freezing demand.

The United Kingdom is projected to rise at 26.2% CAGR through 2036 because regulated storage rules and egg freezing growth create patient education needs. The Human Fertilisation and Embryology Authority reported that egg freezing cycles increased from 2,567 in 2019 to 6,932 in 2023. TFP Fertility, Bourn Hall, CARE Fertility and The Evewell are active local providers. Self-pay patients need help comparing clinic prices, storage renewal rules and return-to-use expectations before paying for a cycle. [5]

What shapes Australia's role?

25.6% CAGR, supported by corporate clinic networks and frozen embryo pathways.

Australia is forecast at 25.6% CAGR through 2036 as corporate clinic networks and frozen embryo pathways keep storage planning central to patient care. The University of New South Wales reported that vitrification was used in 98.1% of thaw blastocyst transfers in 2023. Monash IVF, Virtus Health, Genea and City Fertility are active local providers. Concierge services gain value when patients need one explanation across thaw planning, finance and travel logistics. [10]

How does Spain support cross-border concierge work?

24.7% CAGR, supported by cross-border care and private clinic capacity.

Spain is expected to post 24.7% CAGR through 2036 because private fertility capacity and cross-border patient flows create documentation needs. The Spanish national registry workshop for 2023 activity was scheduled by the Ministry of Health for December 2025. Sociedad Espanola de Fertilidad also reported high assisted reproduction activity across in vitro fertilization and insemination services for 2023. IVI RMA, Instituto Bernabeu, Clinica Tambre and Ginemed are active local providers. Demand favors multilingual guidance, storage consent support and travel-timing coordination. [16]

Who leads the fertility preservation concierge services landscape?

Progyny, Carrot Fertility and Maven Clinic lead through benefit administration, member guidance and employer relationships.

Fertility preservation concierge services are used by employers, health plans, fertility clinics and self-pay patients that need guided decisions before a preservation cycle starts. Progyny competes through fertility benefit services and care management. Carrot Fertility competes through global benefit access, provider networks and payment support. Maven Clinic competes through virtual reproductive health and family-building programs.

Kindbody links employer benefits with owned and affiliated fertility care. WIN supports employers, health plans and consumers through fertility benefit management. ARC Fertility focuses on bundled treatment packages, financing and benefit navigation. Inception Fertility brings clinic network depth through its fertility-care ecosystem.

Competition through 2036 is expected to depend on coverage administration, clinical network quality, patient guidance and storage documentation. Providers with strong intake workflows and outcome reporting are better placed as employers ask for measurable use, lower member confusion and fewer delayed treatment starts.

Adjacent artificial insemination and fertility tracking tools categories matter because concierge providers increasingly sit before, during and after the clinical treatment decision.

Which companies are the key players?

Progyny, Carrot Fertility, Maven Clinic, Kindbody, WIN, ARC Fertility and Inception Fertility.

• Progyny
• Carrot Fertility
• Maven Clinic
• Kindbody
• WIN
• ARC Fertility
• Inception Fertility

Bibliography

• Centers for Disease Control and Prevention. (2024, December 10). ART surveillance.
• Centers for Disease Control and Prevention. (2024, December 10). National ART summary.
• Human Fertilisation and Embryology Authority. (2025, June 26). Fertility treatment 2023: Trends and figures.
• Human Fertilisation and Embryology Authority. (2025, July 31). Egg freezing: A factsheet.
• De Nutte, A. (2025, June 30). IVF and IUI pregnancy rates remain stable across Europe, despite an increasing uptake of single embryo transfer. Focus on Reproduction.
• American Society for Reproductive Medicine. (2026, February 1). Fertility preservation in patients with medical indications: A committee opinion.
• American Society for Reproductive Medicine. (2026, February 1). Fertility preservation and reproduction in patients facing gonadotoxic therapies or gonadectomy: An Ethics Committee opinion.
• RESOLVE: The National Infertility Association. (2025, December 1). About insurance coverage.
• University of New South Wales, National Perinatal Epidemiology and Statistics Unit. (2025, September). Assisted reproductive technology in Australia and New Zealand 2023.
• Australian Government Department of Health, Disability and Ageing. (2025, September 26). Rapid Review of Assisted Reproductive Technology and In Vitro Fertilisation Regulation and Accreditation in Australia.
• Government of India, Ministry of Health and Family Welfare. (2025, August 5). Increase in fertility and ART centres across the country. Rajya Sabha.
• Government of India, Department of Health Research. (n.d.). National ART & Surrogacy Registry.
• Huang, R., Fang, C., Xu, S., et al. (2024). Feasibility analysis of China’s medical insurance coverage for assisted reproductive technology. Scientific Reports, 14, 7027.
• Katagiri, Y., Jwa, S. C., Kuwahara, A., Iwasa, T., Ono, M., Kato, K., Kishi, H., Kuwabara, Y., Taniguchi, F., Harada, M., Iwase, A., & Sugino, N. (2026). Assisted Reproductive Technology in Japan: A summary report for 2023 by the Committee on Professional Scientific Conduct and Clinical Ethics of the Japan Society of Obstetrics and Gynecology. Reproductive Medicine and Biology, 25(1), e70008.
• Comisión Nacional de Reproducción Humana Asistida. (2025, December 17). XVII Workshop Registro Nacional de Actividad 2023 – Registro SEF. Ministerio de Sanidad.
• Sociedad Española de Fertilidad. (2025). La reproducción asistida en España: Una década de datos que consolidan eficacia, seguridad y compromiso social.
• United Nations Department of Economic and Social Affairs. (2025, May 6). World fertility 2024. United Nations.
• Progyny, Inc. (2026, February 26). Progyny, Inc. announces fourth quarter 2025 results.
• Progyny, Inc. (2025, January 28). Progyny, Inc. enhances suite of services with acquisition of BenefitBump.
• Maven Team. (2024, April 17). Maven Clinic expands award-winning Fertility & Family Building solution with focus on natural conception. Maven Clinic.
• Carrot Fertility, Inc. (2024, October 18). Carrot partners with WTW to expand access to fertility and family-building benefits for employers.
• Carrot Fertility, Inc. (2025, July 7). Introducing Sprints: The first — and only — metabolic-fertility program.

This Report Address

• Strategic intelligence on fertility preservation concierge services across service type, preservation pathway and buyer type.
• Segment analysis covering Benefit Management, Egg Freezing, Employers, Virtual Concierge and Elective Preservation.
• Regional outlook covering the United States, India, China, Japan, United Kingdom, Australia and Spain.
• Competitive analysis of Progyny, Carrot Fertility, Maven Clinic, Kindbody, WIN, ARC Fertility and Inception Fertility.
• Service assessment covering care navigation, benefit administration, oncology referral, storage coordination and financial counseling.
• Primary interviews, provider checks, official source review and assisted reproduction data validation support the forecast.

What does the fertility preservation concierge services market cover?

Navigation and benefit administration services for egg, sperm, embryo, ovarian tissue and testicular tissue preservation.

The fertility preservation concierge services market covers structured support that helps individuals and buyers plan, fund and coordinate reproductive material preservation. It differs from fertility treatment because the paid service is navigation and administration. It includes intake, clinic matching, benefit explanation, oncology referral routing, storage choice education and reimbursement support.

What is included in the scope?

Care navigation, preservation planning, benefit administration and referral coordination.

The scope includes care navigation for egg, sperm, embryo, ovarian tissue and testicular tissue preservation. It includes employer and health-plan benefit administration tied to preservation access. It also includes oncofertility referral coordination, storage consent support, financial counseling and claims assistance when the service fee is separate from the clinical procedure.

What is excluded from the scope?

Clinical procedure revenue, medication revenue, laboratory storage fees and fertility devices.

The scope excludes retrieval, thawing, transfer, laboratory work and pharmacy revenue. It excludes long-term cryostorage fees charged directly by laboratories. It also excludes fertility devices, media, instruments and consumables unless they are referenced only as adjacent value-chain categories.

How was the analysis built?

100+ sources, 45+ company portfolios, 28+ countries, 24+ expert checks.

• Primary Research:
  • Primary research includes interviews and structured checks with benefit consultants, fertility clinic operators, employer benefits teams and reproductive health service providers.
• Desk Research:
  • Desk research reviews government fertility registries, professional society guidance, fertility authority publications, company investor filings and official company newsrooms.
• Market-Sizing and Forecasting:
  • Forecasting uses assisted reproduction cycle volume, employer benefits penetration, clinic network capacity and estimated service revenue per covered case.
• Data Validation and Update Cycle:
  • Forecasts are validated through clinic-capacity checks, company disclosure review and country-level assisted reproduction activity. Public service-revenue splits are limited, so segment shares are analyst estimates where direct disclosure is unavailable.